Literature DB >> 7353337

Cholestyramine and spironolactone and their combination in digitoxin elimination.

S G Carruthers, C A Dujovne.   

Abstract

The effects of oral cholestyramine 4 gm 8 times daily and spironolactone 300 mg daily, given independently and in combination, on the elimination rate of digitoxin were studied in 6 healthy subjects pretreated with 0.1 or 0.15 mg oral digitoxin daily for 30 days before each intervention. The mean pretreatment digitoxin concentrations for the group ranged from 21 +/- 2.9 (SD) ng/ml to 28.5 +/- 6.9 ng/ml. The mean control digitoxin half-life (t 1/2) was reduced from 141.6 to 84.4 by treatment with cholestyramine alone. Treatment with spironolactone alone prolonged the mean digitoxin t 1/2 to 192.2 hr. The mean digitoxin t 1/2 after both active drugs was intermediate at 102.9 hr. Spironolactone did not fulfill the expectation from animal studies that it would enhance the clearance of digitoxin by cholestyramine. The prolongation of digitoxin elimination after spironolactone may contraindicate this drug in digitoxin intoxication.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7353337     DOI: 10.1038/clpt.1980.28

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

1.  Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide.

Authors:  P J Neuvonen; K Kivistö; E L Hirvisalo
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

Review 2.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.